TGTX - TG THERAPEUTICS, INC.
29.27
0.240 0.820%
Share volume: 1,204,235
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$29.03
0.24
0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-06-2024 | 08-09-2024 | 11-07-2024 | 03-03-2025 | 05-09-2025 | 08-08-2025 | 11-05-2025 | 02-27-2026 | |
| Assets | |||||||||
| Total Assets | 373.323 M | 401.207 M | 586.014 M | 577.690 M | 656.689 M | 702.613 M | 1.025 B | 1.063 B | |
| Current Assets | 360.581 M | 389.150 M | 574.069 M | 566.359 M | 644.510 M | 663.962 M | 599.765 M | 630.764 M | |
| Inventories | 77.719 M | 81.243 M | 84.669 M | 110.458 M | 157.759 M | 155.202 M | 146.953 M | 125.586 M | |
| Other Current Assets | 8.095 M | 7.047 M | 32.632 M | 15.716 M | 20.390 M | 25.374 M | 55.846 M | 57.580 M | |
| Short Term Investments | 8.095 M | 134.342 M | 145.219 M | 131.106 M | 144.101 M | 122.744 M | 57.501 M | 62.822 M | |
| Total Receivables | 64.982 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 209.785 M | 82.910 M | 195.822 M | 179.894 M | 132.139 M | 129.126 M | 74.081 M | 79.148 M | |
| Total Non-current Assets | 12.742 M | 947.000 K | 1.125 M | 808.000 K | 1.907 M | 28.590 M | 48.757 M | 59.136 M | |
| Property Plant Equipment | 1.428 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Assets | 0.000 | 12.057 M | 11.945 M | 11.331 M | 12.178 M | 38.651 M | 425.259 M | 432.489 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 799.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 373.323 M | 401.207 M | 586.014 M | 577.690 M | 656.689 M | 702.613 M | 1.025 B | 1.063 B | |
| Total liabilities | 213.214 M | 223.639 M | 393.857 M | 355.326 M | 419.400 M | 426.181 M | 417.806 M | 415.233 M | |
| Total current liabilities | 99.684 M | 108.664 M | 125.114 M | 90.679 M | 160.209 M | 171.889 M | 156.810 M | 153.760 M | |
| Accounts Payable | 0.000 | 93.472 M | 101.407 M | 58.296 M | 133.932 M | 134.021 M | 112.336 M | 107.508 M | |
| Other liabilities | 3.244 M | 8.695 M | 8.419 M | 8.133 M | 7.860 M | 7.588 M | 7.308 M | 7.021 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 101.326 M | 102.537 M | 244.158 M | 244.429 M | 244.733 M | 245.037 M | 245.340 M | 245.645 M | |
| Other liabilities | 3.244 M | 8.695 M | 8.419 M | 8.133 M | 7.860 M | 7.588 M | 7.308 M | 7.021 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 160.109 M | 177.568 M | 192.157 M | 222.364 M | 237.289 M | 276.432 M | 607.218 M | 648.020 M | |
| Common stock | 146.209 M | 1.734 B | 1.747 B | 1.761 B | 1.777 B | 1.794 B | 1.813 B | 1.830 B | |
| Retained earnings | -1.525 B | -1.556 B | -1.553 B | -1.529 B | -1.524 B | -1.496 B | -1.105 B | -1.082 B |